Eyebright Medical Technology (Beijing) Co., Ltd. (SHA: 688050)
China
· Delayed Price · Currency is CNY 78.03
-1.52 (-1.91%)
Sep 6, 2024, 3:00 PM CST
Eyebright Medical Technology (Beijing) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | 348.84 | 303.98 | 232.69 | 171.34 | 96.56 | 66.69 | Upgrade
|
| Depreciation & Amortization | 104.63 | 75.49 | 43.35 | 32.04 | 26.67 | 22.39 | Upgrade
|
| Other Amortization | 14.68 | 10.96 | 9.08 | 7.33 | 3.59 | 1.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.07 | -0.11 | -0.01 | -0.02 | 0.15 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5 | -11.7 | -18.58 | -19.59 | -5.11 | -0.37 | Upgrade
|
| Provision & Write-off of Bad Debts | 15.72 | 9.11 | 8.37 | 5.74 | 2.03 | 1.16 | Upgrade
|
| Other Operating Activities | -6.88 | -9.62 | -3.07 | -1.91 | -0.39 | -1.66 | Upgrade
|
| Change in Accounts Receivable | -196.47 | -103.52 | -45.76 | 1.12 | 18.11 | -14.77 | Upgrade
|
| Change in Inventory | -88.25 | -85.12 | -22.82 | 3.35 | 1.67 | -24.42 | Upgrade
|
| Change in Accounts Payable | 60.99 | 21.46 | 21.41 | 15.07 | -20.09 | 13.19 | Upgrade
|
| Change in Other Net Operating Assets | 9.47 | 12.39 | 17.56 | 13.25 | - | - | Upgrade
|
| Operating Cash Flow | 254.71 | 212.62 | 250.13 | 219.3 | 123.35 | 50.49 | Upgrade
|
| Operating Cash Flow Growth | 27.48% | -15.00% | 14.06% | 77.78% | 144.30% | 58.69% | Upgrade
|
| Capital Expenditures | -480 | -370.34 | -271.03 | -311.22 | -118.73 | -141.61 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.43 | 0.43 | 0.04 | - | 0.03 | 0 | Upgrade
|
| Cash Acquisitions | -117.11 | -47.03 | - | - | - | - | Upgrade
|
| Investment in Securities | 460.75 | 439.64 | -51.29 | -120.9 | -474.98 | 200 | Upgrade
|
| Other Investing Activities | 6.67 | 15.97 | 21.44 | 19.75 | 5.97 | 5.59 | Upgrade
|
| Investing Cash Flow | -129.26 | 32.67 | -307.84 | -420.37 | -587.71 | 63.98 | Upgrade
|
| Long-Term Debt Issued | - | 12.16 | 10 | 143.37 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -19.43 | -5.4 | - | -0.44 | -7.71 | Upgrade
|
| Net Debt Issued (Repaid) | 311.09 | -7.27 | 4.6 | 143.37 | -0.44 | -7.71 | Upgrade
|
| Issuance of Common Stock | 15.08 | 13.48 | 1.56 | 24.91 | 823.29 | - | Upgrade
|
| Common Dividends Paid | -65.02 | -61.37 | -44.44 | -30.52 | - | - | Upgrade
|
| Other Financing Activities | -24.4 | -8.41 | -26.79 | -0.02 | -18.12 | 22.61 | Upgrade
|
| Financing Cash Flow | 216.71 | -63.57 | -65.07 | 137.74 | 804.73 | 14.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0.04 | -0.04 | -0.64 | 0.15 | -0.01 | Upgrade
|
| Net Cash Flow | 342.19 | 181.76 | -122.82 | -63.97 | 340.51 | 129.36 | Upgrade
|
| Free Cash Flow | -225.29 | -157.72 | -20.9 | -91.92 | 4.62 | -91.12 | Upgrade
|
| Free Cash Flow Margin | -18.32% | -16.58% | -3.61% | -21.23% | 1.69% | -46.68% | Upgrade
|
| Free Cash Flow Per Share | -1.19 | -0.83 | -0.11 | -0.49 | 0.03 | -0.65 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.01 | 0.26 | Upgrade
|
| Cash Income Tax Paid | 131.82 | 157.93 | 58.75 | 57.3 | 36.58 | 36.38 | Upgrade
|
| Levered Free Cash Flow | -379.74 | -215.88 | -110.16 | -105.6 | 5.29 | -120.27 | Upgrade
|
| Unlevered Free Cash Flow | -370.23 | -209.74 | -108.89 | -105.14 | 5.29 | -120.17 | Upgrade
|
| Change in Net Working Capital | 255.85 | 129.54 | 50.78 | -56.01 | -33.1 | 40.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.